Acanya Gel The combination optimized for both power and tolerability.

Indication and Important Safety Information: Acanya Gel is indicated for the topical treatment of acne vulgaris in patients 12 years of age or older. In controlled clinical trials, the following application-site adverse reactions occurred in less than 0.2% of patients treated with Acanya Gel: application-site pain (0.1%), application-site exfoliation (0.1%), and application-site irritation (0.1%). Of the patients who experienced cutaneous symptoms of erythema, scaling, itching, burning, and/or stinging, regardless of the relationship to therapy, the majority of cases were mild to moderate in severity, occurred early in treatment, and decreased thereafter. Acanya Gel is contraindicated in patients with a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis. Diarrhea, bloody diarrhea, and colitis have been reported with the use of topical clindamycin. Discontinuation is recommended if significant diarrhea develops. Patients are advised to avoid applying in mouth, eyes, or nose, or on lips, and to minimize sun exposure following the application of Acanya Gel.

Please see full prescribing information.
For healthcare professionals only.